 |
A XIII-as faktor, trombin generáció és fibrinolízis vizsgálata krónikus inflammatórikus megbetegedésekben
|
súgó
nyomtatás
|
Ezen az oldalon az NKFI Elektronikus Pályázatkezelő Rendszerében nyilvánosságra hozott projektjeit tekintheti meg.
vissza »



|
 |
Közleményjegyzék |
|
|
Szegedi, I., Orbán-Kálmándi, R., Nagy, A., Sarkady, F., Molnárné Vasas, N., Sik, M., Lánczi, L., Berényi, E., Oláh, L., Crișan, A., Csiba, L., Bagoly, Z.: Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis., PLoS One. 16 (7), 1-16, 2021., 2021 | Eszter Lilla Tóth, Rita Orbán-Kálmándi, Zsuzsa Bagoly, Linda Lóczi, Tamás Deli, Olga Török, Sarolta Molnár, Sándor Baráth, Parvind Singh, Zsuzsanna Hevessy, Éva Katona, Miklós Fagyas, Attila Ádám Szabó, Szabolcs Molnár, Zoárd Tibor Krasznai: Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss, Front Immunol, 2024 (accepted for publication), 2024 | Vivien Stercel, Linda Lóczi, Orsolya Kadenczki, Éva Nemes, Rebeka Hodossy-Takács, Tamás Szabó, Zsuzsa Bagoly: Effect of SARS-CoV-2 mRNA vaccination on thrombin generation and disease activity in children with inflammatory bowel disease, European Congress on Thrombosis and Haemostasis (ECTH), Valencia, Spain, 2023, 2023 | Rita Orbán-Kálmándi: In vitro clot lysis assays for the prediction of outcomes in acute ischemic and hemorrhagic strokes, University of Debrecen, Kálmán Laki Doctorate School, 2022 | Z Bagoly, G Haramura, B Bécsi, F Erdődi, L Muszbek: Inactivation of factor XIII, International Society on Thrombosis and Haemostasis (ISTH) SSC Session, 2023 Montreal, Canada, 2023 | Ghansah Harriet, Orbán-Kálmándi Rita, Debreceni Ildikó Beke, Katona Éva, Rejtő László, Váróczy László, Lóczi Linda, de Laat Bas, Huskens Dana, Kappelmayer János, Bagoly Zsuzsa.: Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma, Thromb Res 2023;234:12-20, 2023 | Natorska J, Corral J, de la Morena-Barrio ME, Bravo-Pérez C, Bagoly Z, Bereczky Z, Treliński J, Witkowski M, Klajmon A, Undas A, Ząbczyk M.: Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype, Thromb Haemost. 2023;123(9):880-891., 2023 | Stercel V, Lóczi L, Kadenczki O, Nemes É, Nagy B Jr, Hodossy-Takács R, Szabó AÁ, Fagyas M, Kappelmayer J, Szabó T, Bagoly Z.: Effect of anti-SARS-CoV-2 BNT162b2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease., Front Immunol. 2023 ;14:1257072., 2023 | N.K. Tóth, T. Tarr, P. Soltész, F. Sarkady, J. Kappelmayer, L. Muszbek, Z. Bagoly: Von Willebrand factor levels in patients with systemic lupus erythematosus and antiphospholipid syndrome, Clinica Chimica Acta Volume 530, Supplement 1, 1 May 2022, Page S176, 2022 | Linda Lóczi, Maria Papp, Nóra Sipeki, Ildikó Beke Debreceni, János Kappelmayer, Zsuzsa Bagoly: Thrombin generation in patients with inflammatory bowel disease, Clinica Chimica Acta Volume 530, Supplement 1, 2022, S158-S159, 2022 | Attila Ádám Szabó, Lóczi Linda, Enikő Edit Enyedi, Papp Mária, Sipeki Nóra, Élthes Zsuzsa Bianka, Tamás Bence Pintér, Palatka Károly, Pályu Eszter, Juhász Lilla, Miklós Fagyas, Zsuzsa Bagoly: Macrophage-secreted enzymes can help physicians treat inflammatory bowel disease, Wordlab-Euromedlab 2023 Congress, 2023 | Bagoly Zsuzsa, Muszbek László: Factor XIII: what does it look like?, JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019; 17:714-16., 2019 | Bereczky Zsuzsanna, Balogh László, Bagoly Zsuzsa: Inherited thrombophilia and the risk of myocardial infarction: current evidence and uncertainties, KARDIOLOGIA POLSKA 77: (4) pp. 419-429., 2019 | Szegedi I, Nagy A, Székely EG, Czuriga-Kovács KR, Sarkady F, Lánczi IL, Berényi E, Csiba L, Bagoly Z: PAI-1 5G/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients, ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY 6: (11) pp. 2240-2250., 2019 | Bryk AH, Siudut J, Broniatowska E, Bagoly Z, Baráth B, Katona É, Undas A: Sex-specific alteration to alpha 2-antiplasmin incorporation in patients with type 2 diabetes, THROMBOSIS RESEARCH 185: pp. 55-62., 2020 | Lóczi Linda, Kappelmayer János, Tarr Tünde, Bagoly Zsuzsa: Antiphospholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties, KARDIOLOGIA POLSKA 78: (1) pp. 6-14., 2020 | Kattula Sravya, Bagoly Zsuzsa, Tóth Noémi Klára, Muszbek László, Wolberg Alisa S.: The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations, JOURNAL OF THROMBOSIS AND HAEMOSTASIS 18: (4) pp. 885-894., 2020 | Bagoly Zsuzsa, Hajas Orsolya, Urbancsek Réka, Kiss Alexandra, Fiak Edit, Sarkady Ferenc, Tóth Noémi Klára, Orbán-Kálmándi Rita, Kovács Kitti Bernadett, Nagy László, Nagy Attila, Kappelmayer János, Csiba László, Csanádi Zoltán: Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists, JOURNAL OF CLINICAL MEDICINE 9: (9) 3050, 2020 | Szegedi István, Orbán-Kálmándi Rita, Csiba László, Bagoly Zsuzsa: Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature, JOURNAL OF CLINICAL MEDICINE 9: (10) 3137, 2020 | Zabczyk M, Natorska J, Bagoly Z, Sarkady F, Barath B, Katona E, Bryk A, Zettl K, Wisniewski JR, Undas A.: Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase., J Physiol Pharmacol, 2020 | Bagoly Zsuzsa, Baráth Barbara, Orbán-Kálmándi Rita, Szegedi István, Bogáti Réka, Sarkady Ferenc, Csiba László, Katona Éva: Incorporation of alpha 2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients, BIOMOLECULES 11: (3) 347, 2021 | Orbán-Kálmándi Rita, Szegedi István, Sarkady Ferenc, Fekete István, Fekete Klára, Vasas Nikolett, Berényi Ervin, Csiba László, Bagoly Zsuzsa: A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis, SCIENTIFIC REPORTS 11: (1) 12713, 2021 | Linda Lóczi, Rita Orbán-Kálmándi, Tamás Árokszállási, István Fekete, Klára Fekete, Máté Héja, Judit Tóth, László Csiba, Zsuzsa Bagoly: Thrombin generation as a predictor of outcomes in patients with non-traumatic intracerebral hemorrhage, Front Neurol, 2022; 13: 912664, 2022 | Edina Gabriella Székely, Rita Orbán-Kálmándi, István Szegedi, Éva Katona, Barbara Baráth, Katalin Réka Czuriga-Kovács, Linda Lóczi, Nikolett Vasas, István Fekete, Klára Fekete , Ervin Berényi, László Oláh, László Csiba, Zsuzsa Bagoly: Low α2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intrav, Front Cardiovasc Med, 2022; 9: 901286, 2022 | Ghansah Harriet, Debreceni Ildikó Beke, Váróczy László, Rejtő László, Lóczi Linda, Bagoly Zsuzsa, Kappelmayer János: Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated protein C, THROMBOSIS RESEARCH 223: pp. 44-52., 2023 | Zabczyk M, Natorska J, Bagoly Z, Sarkady F, Barath B, Katona E, Bryk A, Zettl K, Wisniewski JR, Undas A.: Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase., J Physiol Pharmacol, 2020 | Stercel V, Linda L, Kadenczki O, Nemes É, Hodossy-Takács R, Szabó T, Bagoly Z.: Effect of SARS-CoV-2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease, ISTH 2022 London, 2022 | Tóth NK, Tarr T, Soltész P, Sarkady F, Kappelmayer J, Muszbek L, Bagoly Z.: VON WILLEBRAND FACTOR LEVELS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME,, IFCC Worldlab 2022, 2022 | Lóczi L, Papp M, Sipeki N, Beke Debreceni I, Kappelmayer J, Bagoly Z.:: Thrombin generation in patients with inflammatory bowel disease, IFCC Worldlab Congress, 2022, 2022 | Bagoly Zsuzsa, Baráth Barbara, Orbán-Kálmándi Rita, Szegedi István, Bogáti Réka, Sarkady Ferenc, Csiba László, Katona Éva: Incorporation of alpha 2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients, BIOMOLECULES 11: (3) 347, 2021 | Bagoly Zsuzsa, Behme Daniel, Kaesmacher Johannes, De Lizarrondo Sara Martinez: Editorial: Hemostasis and Stroke, FRONTIERS IN NEUROLOGY 12: 737556, 2021 | Orbán-Kálmándi R, Árokszállási T, Fekete I, Fekete K, Héja M, Tóth J, Sarkady F, Csiba L, Bagoly Z.: A Modified in vitro Clot Lysis Assay Predicts Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients - The IRONHEART Study, FRONTIERS IN NEUROLOGY 12: 613441, 2021 | Orbán-Kálmándi Rita, Szegedi István, Sarkady Ferenc, Fekete István, Fekete Klára, Vasas Nikolett, Berényi Ervin, Csiba László, Bagoly Zsuzsa: A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis, SCIENTIFIC REPORTS 11: (1) 12713, 2021 | Bagoly Z.: ABO blood group type and the risk of venous thromboembolism: the impact of interactions, Pol Arch Intern Med, 2022; 132:16378, 2022 | Linda Lóczi, Rita Orbán-Kálmándi, Tamás Árokszállási, István Fekete, Klára Fekete, Máté Héja, Judit Tóth, László Csiba, Zsuzsa Bagoly: Thrombin generation as a predictor of outcomes in patients with non-traumatic intracerebral hemorrhage, Front Neurol, 2022; 13: 912664, 2022 | Edina Gabriella Székely, Rita Orbán-Kálmándi, István Szegedi, Éva Katona, Barbara Baráth, Katalin Réka Czuriga-Kovács, Linda Lóczi, Nikolett Vasas, István Fekete, Klára Fekete , Ervin Berényi, László Oláh, László Csiba, Zsuzsa Bagoly: Low α2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intrav, Front Cardiovasc Med, 2022; 9: 901286, 2022 | Lóczi L, Papp M, Sipeki N, Beke Debreceni I, Kappelmayer J, Bagoly Z.: Thrombin generation in patients with inflammatory bowel disease, IFCC Worldlab Congress, 2020, 2020 | Tóth NK, Tarr T, Soltész P, Sarkady F, Kappelmayer J, Muszbek L, Bagoly Z.: VON WILLEBRAND FACTOR LEVELS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME, IFCC Worldlab 2020, 2020 | Bagoly Zsuzsa, Muszbek László: Factor XIII: what does it look like?, JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019; 17:714-16., 2019 | Bagoly Zsuzsa, Szegedi Istvan, Kalmandi Rita, Toth Noemi Klara, Csiba Laszlo: Markers of Coagulation and Fibrinolysis Predicting the Outcome of Acute Ischemic Stroke Thrombolysis Treatment: A Review of the Literature, FRONTIERS IN NEUROLOGY 10: 513, 2019 | Bereczky Zsuzsanna, Balogh László, Bagoly Zsuzsa: Inherited thrombophilia and the risk of myocardial infarction: current evidence and uncertainties, KARDIOLOGIA POLSKA 77: (4) pp. 419-429., 2019 | Bryk AH, Siudut J, Broniatowska E, Bagoly Z, Baráth B, Katona É, Undas A: Sex-specific alteration to α2-antiplasmin incorporation in patients with type 2 diabetes, THROMBOSIS RESEARCH 2019: p. accepted for publication doi.org/10.1016/j.thromres.2019.09.032., 2019 | Lóczi Linda, Kappelmayer János, Tarr Tünde, Bagoly Zsuzsa: Antiphosholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties, KARDIOLOGIA POLSKA 1: p. 10.33963/KP.15090.., 2019 | Szegedi I, Nagy A, Székely EG, Czuriga-Kovács KR, Sarkady F, Lánczi IL, Berényi E, Csiba L, Bagoly Z: PAI-1 5G/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients, ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY 6: (11) pp. 2240-2250., 2019 | Teráz-Orosz Adrienn, Csapó Andrea, Bagoly Zsuzsa, Székely Edina Gabriella, Tóth Eszter, Kovács Bettina, Bereczky Zsuzsanna, Muszbek László, Katona Éva: A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids, JOURNAL OF IMMUNOLOGICAL METHODS 471: pp. 27-33., 2019 | Tóth NK, Tarr T, Soltész P, Lóczi L, Muszbek L, Bagoly Z.: Thrombin generation in patients with systemic lupus erythematosus (SLE), Clinica Chimica Acta 493 (2019) S379–S433, W055, 2019 | J. Kappelmayer, I. Beke Debreceni, G. Szabó, R. Hudák, J. Tóth, Z. Bagoly: The thrombin generation assay: A research method or a diagnostic test?, Clinica Chimica Acta 493 (2019) S379–S433, W065, 2019 | Z. Bagoly , N.K. Tóth , T. Tarr , P. Soltész , É. Katona , Z.A. Mezei , L. Muszbek: FXIII levels in patients with systemic lupus erythematosus and antiphospholipid syndrome, Clinica Chimica Acta 493 (2019) S379–S433; W112, 2019 | Bagoly Zsuzsa, Szegedi Istvan, Kalmandi Rita, Toth Noemi Klara, Csiba Laszlo: Markers of Coagulation and Fibrinolysis Predicting the Outcome of Acute Ischemic Stroke Thrombolysis Treatment: A Review of the Literature, FRONTIERS IN NEUROLOGY 10: 513, 2019 | Bagoly Zsuzsa, Hajas Orsolya, Urbancsek Réka, Kiss Alexandra, Fiak Edit, Sarkady Ferenc, Tóth Noémi Klára, Orbán-Kálmándi Rita, Kovács Kitti Bernadett, Nagy László, Nagy Attila, Kappelmayer János, Csiba László, Csanádi Zoltán: Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists, JOURNAL OF CLINICAL MEDICINE 9: (9) 3050, 2020 | Bryk AH, Siudut J, Broniatowska E, Bagoly Z, Baráth B, Katona É, Undas A: Sex-specific alteration to alpha 2-antiplasmin incorporation in patients with type 2 diabetes, THROMBOSIS RESEARCH 185: pp. 55-62., 2020 | Hajas Orsolya, Bagoly Zsuzsa, Tóth Noémi Klára, Urbancsek Réka, Kiss Alexandra, Kovács Kitti B, Sarkady Ferenc, Nagy Attila, V. Oláh Anna, Nagy László, Clemens Marcell, Csiba László, Csanádi Zoltán: Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques, CARDIOLOGY RESEARCH AND PRACTICE 2020: 1570483, 2020 | Kattula Sravya, Bagoly Zsuzsa, Tóth Noémi Klára, Muszbek László, Wolberg Alisa S.: The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations, JOURNAL OF THROMBOSIS AND HAEMOSTASIS 18: (4) pp. 885-894., 2020 | Lóczi Linda, Kappelmayer János, Tarr Tünde, Bagoly Zsuzsa: Antiphospholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties, KARDIOLOGIA POLSKA 78: (1) pp. 6-14., 2020 | Szegedi István, Orbán-Kálmándi Rita, Csiba László, Bagoly Zsuzsa: Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature, JOURNAL OF CLINICAL MEDICINE 9: (10) 3137, 2020 |

|
|
|

|

|

|

vissza »
|
 |
|